Saltar al contenido
Merck
Todas las fotos(1)

Key Documents

View All Documentation

219878

Sigma-Aldrich

4-Hydroxyindole

99%

Sinónimos:

4-Indolol, 4-Hydroxyindole

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C8H7NO
Número de CAS:
2380-94-1
Peso molecular:
133.15
Beilstein/REAXYS Number:
114905
EC Number:
219-177-2
MDL number:
MFCD00005667
UNSPSC Code:
12352100
PubChem Substance ID:
24853151
NACRES:
NA.22

assay

99%

form

solid

mp

97-99 °C (lit.)

SMILES string

Oc1cccc2[nH]ccc12

InChI

1S/C8H7NO/c10-8-3-1-2-7-6(8)4-5-9-7/h1-5,9-10H

InChI key

NLMQHXUGJIAKTH-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

General description

Glucouridination of 4-hydroxyindole by human uridine 5′-diphospho-glucuronosyltransferase has been repotrted.

pictograms

Exclamation mark
GHS07

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Los clientes también vieron

Slide 1 of 3

1 of 3

4-Bromoindole 96%

Sigma-Aldrich

524336

4-Bromoindole

Psilocybin solution 1.0 mg/mL in acetonitrile: water (1:1), ampule of 1 mL, certified reference material, Cerilliant®

Supelco

P-097

Psilocybin solution

7-Methylindole 97%

Sigma-Aldrich

M51490

7-Methylindole

Marek Bednarski et al.
Archiv der Pharmazie, 349(3), 211-223 (2016-02-09)
β-Adrenergic receptor antagonists are important therapeutics for the treatment of cardiovascular disorders. In the group of β-blockers, much attention is being paid to the third-generation drugs that possess important ancillary properties besides inhibiting β-adrenoceptors. Vasodilating activity of these drugs is
Stefan W Toennes et al.
Journal of pharmaceutical and biomedical analysis, 140, 215-222 (2017-04-04)
Each year, synthetic cannabinoids are occurring in high numbers in the illicit drug market, but data on their pharmacology and toxicology are scarcely available. Therefore, a pilot study was performed to assess adverse effects of JWH-018, which is one of
Alexandra M Adams et al.
Metabolic engineering, 56, 111-119 (2019-09-25)
Psilocybin, the prodrug of the psychoactive molecule psilocin, has demonstrated promising results in clinical trials for the treatment of addiction, depression, and post-traumatic stress disorder. The development of a psilocybin production platform in a highly engineerable microbe could lead to
Shalenie P den Braver-Sewradj et al.
Current drug metabolism, 19(4), 370-381 (2018-01-11)
Inter-individual variability in hepatic drug metabolizing enzyme (DME) activity is a major contributor to heterogeneity in drug clearance and safety. Accurate data on expression levels and activities of DMEs is an important prerequisite for in vitro-in vivo extrapolation and in
Gavin Carr et al.
Journal of medicinal chemistry, 51(9), 2634-2637 (2008-04-09)
Synthetic analogues of the sponge natural product exiguamine A (3) have been prepared and evaluated for their ability to inhibit indoleamine 2,3-dioxygenase in vitro.
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico